High Flow Oxygen VERSUS Non Invasive Ventilation Associated to Automated

Status Completed

Clinical Trial Summary

Extubation stay at high risk of reintubation even scheduled and in the best condition of hematosis. Re-intubation's rate in main studies in chronic obstructive diseases reach to 20% and it is associated to a higher mortality, higher pneumonia under mechanic ventilation, and higher duration of hospitalization especially in intensive care units. Place of NIV in this situation is still on evaluation. A recent meta-analysis demonstrates that use of NIV in post-extubation in COPD seems to decrease re-intubation rate. HFO, thanks to its properties (oxygen, humidification and heat with high flow) could be useful in this population in ventilatory weaning. Compared to oxygen conventional therapy with high-concentration mask, HFO seems to be as efficient and better tolerated. A recent study shows that HFO is non-inferior to NVI in post-extubation in patient with high risk of re-intubation. Furthermore, oxygenation in post-extubation should be optimized to avoid hypoxemia and hypercapnia in this patient at risk of hypoventilation. Place of AFOT could improve hematosis by providing adapted flow of oxygen to each patient. The investigator choose the hypothesis for this study that HFO is as effective and tolerated in post-extubation than NIV with AFOT.

Clinical Trial Description

A recent meta-analysis demonstrates that use of NIV in post-extubation in obstructive chronic bronchopathies seems to decrease re-intubation rate. High Flow Oxygen, thanks to its properties (oxygen, humidification and heat with high flow) could be useful in this population in ventilatory weaning. Compared to oxygen conventional therapy with high-concentration mask, High Flow Oxygen seems to be as efficient and better tolerated . A recent study shows that High Flow Oxygen is non-inferior to Non Invasive Ventilation in post-extubation in patient with high risk of re-intubation. Furthermore, oxygenation in post-extubation should be optimized to avoid hypoxemia and hypercapnia in this patient at risk of hypoventilation. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03632577
Study type	Interventional
Source	University Hospital, Toulouse
Contact
Status	Completed
Phase	N/A
Start date	December 19, 2017
Completion date	October 15, 2019

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT03376204` - Pain Mechanisms in Patients With Bronchiectasis
Not yet recruiting	`NCT05902702` - Isotonic Saline for Children With Bronchiolitis	N/A
Recruiting	`NCT05246098` - REVIVe: Frailty, Rehabilitation, and Outcomes in Critically Ill Adult and Pediatric Survivors of COVID-19 or ARI
Completed	`NCT04467190` - Investigation of Inflammacheck to Measure Exhaled Breath Condensate Hydrogen Peroxide in Respiratory Conditions
Not yet recruiting	`NCT05374148` - Respiratory Health Problems Among Workers in Ferrosilicon Alloys Industry in Aswan-Eygpt.
Recruiting	`NCT04502368` - Fiberoptic Bronchoscopy and Bronchoalveolar Lavage in Critically Ill Ventilated Patients
Recruiting	`NCT05775952` - Airway Remodeling and Rhinovirus in Asthmatics
Active, not recruiting	`NCT02681848` - What Are the Effects of Varenicline Compared With Nicotine Replacement Therapy on Long Term Smoking Cessation and Clinically Important Outcomes?
Recruiting	`NCT06002685` - Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention	N/A
Enrolling by invitation	`NCT03319446` - Collection of Anonymized Samples	N/A
Recruiting	`NCT04287959` - SWISH Trial (Strategies for Weaning Infants on Supportive High Flow)	N/A
Completed	`NCT05017727` - Closed-loop Oxygen Control in Ventilated Infants Born at or Near Term
Completed	`NCT04607330` - Protein Top-up Acceptability Study for Patients With Increased Protein Needs	N/A
Completed	`NCT03334916` - A Clinical Trial to Evaluate the Efficacy and Safety of YMC026 in Respiratory Disease Patients	Phase 4
Completed	`NCT04649736` - Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients	N/A
Completed	`NCT03661801` - Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions
Enrolling by invitation	`NCT03322254` - How Respiratory Pathogens Panel Results Affect Patients' Plan of Care
Recruiting	`NCT03937583` - Screening for Cancer in Patients With Unprovoked VTE	Phase 4
Not yet recruiting	`NCT06026163` - Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress	Phase 2/Phase 3
Completed	`NCT04581096` - Mapping COVID-19 Spread in a Tertiary Hospital

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

High Flow Oxygen VERSUS Non Invasive Ventilation Associated to Automated Flow Oxygen Titration After Patient Extubation — RespiFLOW

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms